Michael Handelman
2012 - Lion Biotechnologies
In 2012, Michael Handelman earned a total compensation of $180K as Chief Financial Officer at Lion Biotechnologies.
Compensation breakdown
| Salary | $180,000 |
|---|---|
| Total | $180,000 |
Handelman received $180K in salary, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Michael Handelman's compensation ranked 10,990th out of 11,487 executives tracked by ExecPay. In other words, Handelman earned more than 4.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,990 out of 11,487 | 4th |
Division Manufacturing | 4,090 out of 4,253 | 4th |
Major group Chemicals And Allied Products | 1,144 out of 1,198 | 5th |
Industry group Drugs | 876 out of 920 | 5th |
Industry Biological Products, Except Diagnostic Substances | 156 out of 160 | 3rd |
Source: SEC filing on April 30, 2015.